These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 11156231)

  • 1. Detection of epidermal growth factor receptor in the serum of patients with cervical carcinoma.
    Oh MJ; Choi JH; Kim IH; Lee YH; Huh JY; Park YK; Lee KW; Chough SY; Joo KS; Ku BS; Saw HS
    Clin Cancer Res; 2000 Dec; 6(12):4760-3. PubMed ID: 11156231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of epidermal growth factor receptor in the serum of gastric carcinoma patients.
    Choi JH; Oh JY; Ryu SK; Kim SJ; Lee NY; Kim YS; Yi SY; Shim KS; Han WS
    Cancer; 1997 May; 79(10):1879-83. PubMed ID: 9149012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic value of serum epidermal growth factor receptor level in patients with non-small cell lung cancer.
    Ciledağ A; Kaya A; Yetkin O; Poyraz B; Savaş I; Numanoğlu N; Savaş H
    Tuberk Toraks; 2008; 56(4):390-5. PubMed ID: 19123074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum epidermal growth factor receptor/HER-2 predicts poor survival in patients with metastatic breast cancer.
    Souder C; Leitzel K; Ali SM; Demers L; Evans DB; Chaudri-Ross HA; Hackl W; Hamer P; Carney W; Lipton A
    Cancer; 2006 Nov; 107(10):2337-45. PubMed ID: 17048231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum vascular endothelial growth factor (VEGF) and VEGF-C levels as tumor markers in patients with cervical carcinoma.
    Mitsuhashi A; Suzuka K; Yamazawa K; Matsui H; Seki K; Sekiya S
    Cancer; 2005 Feb; 103(4):724-30. PubMed ID: 15637689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum EGFR and serum HER-2/neu are useful predictive and prognostic markers in metastatic breast cancer patients treated with metronomic chemotherapy.
    Sandri MT; Johansson HA; Zorzino L; Salvatici M; Passerini R; Maisonneuve P; Rocca A; Peruzzotti G; Colleoni M
    Cancer; 2007 Aug; 110(3):509-17. PubMed ID: 17559147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzyme immunoassay of human epidermal growth factor receptor (hEGFR).
    Kumar RR; Meenakshi A; Sivakumar N
    Hum Antibodies; 2001; 10(3-4):143-7. PubMed ID: 11847425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutant p53 protein in the serum of patients with colorectal cancer: Correlation with the level of carcinoembryonic antigen and serum epidermal growth factor receptor.
    Abdel-Aziz MM; Lotfy M; El-Kady IM; Abozaid M
    Cancer Detect Prev; 2009; 32(4):329-35. PubMed ID: 16632243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated serum vascular endothelial growth factor and decreased survival in advanced laryngeal carcinoma.
    Teknos TN; Cox C; Yoo S; Chepeha DB; Wolf GT; Bradford CR; Carey TE; Fisher SG
    Head Neck; 2002 Nov; 24(11):1004-11. PubMed ID: 12410536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated serum epidermal growth factor receptor level is correlated with lymph node metastasis in lung cancer.
    Sasaki H; Yukiue H; Mizuno K; Sekimura A; Konishi A; Yano M; Kaji M; Kiriyama M; Fukai I; Yamakawa Y; Fujii Y
    Int J Clin Oncol; 2003 Apr; 8(2):79-82. PubMed ID: 12720099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative plasma HER2 and epidermal growth factor receptor for staging and prognostication in patients with clinically localized prostate cancer.
    Shariat SF; Bensalah K; Karam JA; Roehrborn CG; Gallina A; Lotan Y; Slawin KM; Karakiewicz PI
    Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5377-84. PubMed ID: 17875766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum concentrations of interleukin-8, vascular endothelial growth factor, and epidermal growth factor receptor in patients with squamous cell cancer of the head and neck.
    Gokhale AS; Haddad RI; Cavacini LA; Wirth L; Weeks L; Hallar M; Faucher J; Posner MR
    Oral Oncol; 2005 Jan; 41(1):70-6. PubMed ID: 15598588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninvasive squamous lesions in the urinary bladder: a clinicopathologic analysis of 29 cases.
    Guo CC; Fine SW; Epstein JI
    Am J Surg Pathol; 2006 Jul; 30(7):883-91. PubMed ID: 16819332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclooxygenase-2 and epidermal growth factor receptor expressions in different histological subtypes of cervical carcinomas.
    Baltazar F; Filho AL; Pinheiro C; Moreira MA; Queiroz GS; Oton GJ; Júnior AF; Ribeiro LF; Schmitt FC
    Int J Gynecol Pathol; 2007 Jul; 26(3):235-41. PubMed ID: 17581404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated serum epidermal growth factor receptor level in stage IV thymoma.
    Sasaki H; Yukiue H; Sekimura A; Mizuno K; Konishi A; Yano M; Fukai I; Fujii Y
    Surg Today; 2004; 34(5):477-9. PubMed ID: 15108095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased serum level of epidermal growth factor receptor in liver cancer patients and its association with exposure to arsenic.
    Sung TI; Wang YJ; Chen CY; Hung TL; Guo HR
    Sci Total Environ; 2012 May; 424():74-8. PubMed ID: 22446113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble epidermal growth factor receptor (sEGFR/sErbB1) as a potential risk, screening, and diagnostic serum biomarker of epithelial ovarian cancer.
    Baron AT; Cora EM; Lafky JM; Boardman CH; Buenafe MC; Rademaker A; Liu D; Fishman DA; Podratz KC; Maihle NJ
    Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):103-13. PubMed ID: 12582019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membranous expression and prognostic implications of epidermal growth factor receptor protein in human renal cell cancer.
    Merseburger AS; Hennenlotter J; Simon P; Kruck S; Koch E; Horstmann M; Kuehs U; Küfer R; Stenzl A; Kuczyk MA
    Anticancer Res; 2005; 25(3B):1901-7. PubMed ID: 16158924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between serological immune response analyzed by a new ELISA for HPV-16/18 E7 oncoprotein and clinical characteristics of cervical cancer patients.
    Ravaggi A; Romani C; Pasinetti B; Tassi RA; Bignotti E; Bandiera E; Odicino FE; Ragnoli M; Donzelli C; Falchetti M; Calza S; Santin AD; Pecorelli S
    Arch Virol; 2006 Oct; 151(10):1899-916. PubMed ID: 16732494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of serum osteoprotegerin levels in patients with bladder carcinoma.
    Mizutani Y; Matsubara H; Yamamoto K; Nan Li Y; Mikami K; Okihara K; Kawauchi A; Bonavida B; Miki T
    Cancer; 2004 Oct; 101(8):1794-802. PubMed ID: 15386310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.